Table 2

Available antidiabetic agents for treatment of type 2 diabetes

Sulfonylureas
    First generation
    Second generation
    Third generation
    Modified release
Glinides
    Nonsulfonylureic
    Amino acid derivatives
Biguanides
    Metformin
Thiazolidinediones
    Rosiglitazone
    Pioglitazone
Fixed-dose oral hypoglycemic agents combinations
    α-Glucosidase inhibitors
        Acarbose
        Voglibose
    Insulin
        Regular
        Long-acting
        Pre-mixed
    Insulin analogs
        Rapid-acting
        Long-acting
        Inhaled
    GLP-1 analogs
    Dipeptidyl peptidase-4 inhibitors
    Amylin analog